Moreover, In IBD, excessive activation of the NF-κB pathway, triggered by TNF-α, leads to intestinal inflammation and dysfunction, but pretreatment with C3G inhibits this pathway and improves cellular redox status in caco-2 cells (179). The gene discussed is NFKB1; the disease is irritable bowel syndrome.